The influence of lipoproteina(a) on cardio-vascular diseases

• Egile Nagusiak: Monika Maj-Dziedzic (Egilea), Anna Brzozowska (Egilea), Marcelina Sikora (Egilea), Marta Zarzycka (Egilea), Ines Plewniok (Egilea), Jeremiasz Dubiel (Egilea), Adrian Maj (Egilea), Greta Śmietana (Egilea), Martyna Warno (Egilea), Wiktor Kozik (Egilea)
• Formatua: Liburua
• Argitaratua: Kazimierz Wielki University, 2024-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction The current evidence from 2022 published by European Atherosclerosis Society brings the importance of the level of lipoprotein(a) and its influence on the human health.  Especially atherosclerotic cardio-vascular events such as myocardial infarction, heart failure, stroke, atheroscleros...